Journey Medical Corp (DERM)
3.93
+0.13
(+3.42%)
USD |
NASDAQ |
May 31, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Total Long Term Debt (Quarterly): 14.68M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.68M |
December 31, 2023 | 14.62M |
September 30, 2023 | 0.00 |
June 30, 2023 | 9.942M |
March 31, 2023 | 22.84M |
December 31, 2022 | 22.77M |
September 30, 2022 | 19.81M |
June 30, 2022 | 14.79M |
Date | Value |
---|---|
March 31, 2022 | 14.78M |
December 31, 2021 | 0.812M |
September 30, 2021 | 14.97M |
June 30, 2021 | 5.245M |
March 31, 2021 | 0.00 |
December 31, 2020 | 5.22M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
22.84M
Maximum
Mar 2023
10.03M
Average
12.28M
Median
Total Long Term Debt (Quarterly) Benchmarks
Fortress Biotech Inc | 64.42M |
Stereotaxis Inc | 0.00 |
GT Biopharma Inc | -- |
Cara Therapeutics Inc | 0.00 |
FibroGen Inc | 72.21M |